Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
10/1/2024
Akeso's Cadonilimab Receives Second Indication Approval from NMPA
10/1/2024
Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China
10/1/2024
Genentech to Acquire Regor Pharma’ Next-Generation CDK Inhibitor Port...
10/1/2024
Alphamab and CSPC Enter a Licensing Deal on Anti-HER2 BsADC JSKN003 in...
10/1/2024
HUTCHMED Announces Japan Approval for FRUZAQLA (fruquintinib) Received...
10/1/2024
Kailera Secures $400M Series A Funding to Develop Obesity and Diabetes...
9/27/2024
Jixing Pharma Secures $2.75M in Series D+ Financing from Apeloa Hong K...
9/27/2024
Ribo and Pheiron Enter Strategic Deal for AI-assisted Drug Development...
9/27/2024
TJ Biopharma Secures €213M Deal with Sanofi for Greater China Rights ...
9/27/2024
China Rises as a Major Player in Oncology with ADCs Boom: GlobalData
9/27/2024
Daehwa Pharm's Liporaxel Gains Chinese Approval to Treat Gastric Cance...
9/26/2024
Bayer Opens First Co.Lab in China in Shanghai
9/24/2024
LongBio Secures CNY 100M in Series B2 Financing to Advance Antibody Th...
9/23/2024
AstraZeneca Korea Launches Open Innovation Program to Support Korean B...
9/20/2024
Ocumension Therapeutics's ZERVIATE Approved in China
9/19/2024
Kenvue Targets Innovation to Capitalize on China's Expanding Consumer ...
9/19/2024
Kite Sells Stake in Fosun JV, Giving Chinese Partner Full Control of C...
9/19/2024
Celregen Thera Secures CNY Multi-Millions in Angel Round Financing
9/18/2024
China to Accelerate Approval of Innovative Drugs and Medical Devices, ...
9/13/2024
China Courts Global Pharma with Promises of Faster Drug Approvals and ...
9/13/2024
Organon Enters into China Licensing Deal for Fertility Asset with Bao ...
9/13/2024
Fosun Pharma to Acquire Full Ownership of Fosun Kite and Strengthens P...
9/12/2024
Allergan Aesthetics Launches BOTOX Cosmetic for MMP in China
9/11/2024
UKM and ChemPartner Forge Strategic Alliance to Revolutionize Medical ...
9/11/2024
China to Implement Comprehensive Measures to Enhance Insurance Sector ...
9/10/2024
AstraZeneca CEO Defends China Business amid Staff Arrests
9/9/2024
China Eases Foreign Investment Restrictions on Manufacturing, Healthc...
9/9/2024
JIXING Announces Positive Results from Phase 3 JX02002 Trial of Etripa...
9/6/2024
AstraZeneca Agrees Clinical Research Deal on Solid Tumors with BestBra...
9/5/2024
China to Waive Import Tariffs on Drugs and Medical Devices in Hainan's...
Page:
18
/
23
Total number of articles:
663
:
[First]
[<<]
[16]
[17]
[18]
[19]
[20]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit